Market Access Insights
Access the relevant market access data and insights you need on health plans, policy restrictions, PBMs, providers, and more
Report
September 22, 2010
Formulary Advantages in Immune Biologics: Brand Maneuvering in a Market Increasingly Constrained by Limited Payer Reimbursement
Immune diseases such as rheumatoid arthritis, psoriasis, inflammatory bowel disease, psoriatic arthritis and ankylosing spondylitis produce a substantial amount of human suffering and disability. Biol…
